117
Views
11
CrossRef citations to date
0
Altmetric
Perspective

Future of tissue engineering in rheumatic diseases

, &
Pages 283-287 | Published online: 19 Feb 2007

Bibliography

  • FIRESTEIN GS: Evolving concepts of rheumatoid arthritis. Nature (2003) 423(6937):356-361.
  • STEADMAN JR, RODKEY WG, RODRIGO JJ: Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin. Orthop. (2001) (391 Suppl.):S362-S369.
  • HANGODY L, FULES P: Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. J. Bone Joint Surg. Am. (2003) 85-A(Suppl. 2):25-32.
  • BRITTBERG M, LINDAHL A, NILSSON A et al.: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. (1994) 331(14):889-895.
  • SITTINGER M, HUTMACHER DW, RISBUD MV: Current strategies for cell delivery in cartilage and bone regeneration. Curr. Opin. Biotechnol. (2004) 15(5):411-418.
  • SITTINGER M, BURMESTER GR: Can engineered cartilage transplants be used for treating rheumatic diseases? Nat. Clin. Pract. Rheumatol. (2006) 2(4):172-174.
  • BARRY FP, MURPHY JM: Mesenchymal stem cells: clinical applications and biological characterization. Int. J. Biochem. Cell Biol. (2004) 36(4):568-584.
  • JORGENSEN C, DJOUAD F, FRITZ V et al.: Mesenchymal stem cells and rheumatoid arthritis. Joint Bone Spine (2003) 70(6):483-485.
  • KUO CK, LI WJ, MAUCK RL, TUAN RS: Cartilage tissue engineering: its potential and uses. Curr. Opin. Rheumatol. (2006) 18(1):64-73.
  • RYAN JM, BARRY FP, MURPHY JM, MAHON BP: Mesenchymal stem cells avoid allogeneic rejection. J. Inflamm. (London) (2005) 2:8.
  • MURPHY JM, FINK DJ, HUNZIKER EB, BARRY FP: Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum. (2003) 48(12):3464-3474.
  • DE BARI C, DELL’ACCIO F, LUYTEN FP: Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum. (2004) 50(1):142-150.
  • MURPHY JM, DIXON K, BECK S et al.: Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum. (2002) 46(3):704-713.
  • VILQUIN JT, ROSSET P: Mesenchymal stem cells in bone and cartilage repair: current status. Regenerative Med. (2006) 1(4):589-604.
  • ERGGELET C, SITTINGER M, LAHM A: The arthroscopic implantation of autologous chondrocytes for the treatment of full-thickness cartilage defects of the knee joint. Arthroscopy (2003) 19(1):108-110.
  • WAKITANI S, GOTO T, PINEDA SJ et al.: Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J. Bone Joint Surg. Am. (1994) 76(4):579-592.
  • WAKITANI S, IMOTO K, YAMAMOTO T et al.: Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage (2002) 10(3):199-206.
  • TANAKA T, KOMAKI H, CHAZONO M, FUJII K: Use of a biphasic graft constructed with chondrocytes overlying a beta-tricalcium phosphate block in the treatment of rabbit osteochondral defects. Tissue Eng. (2005) 11(1-2):331-339.
  • WAKITANI S, AOKI H, HARADA Y et al.: Embryonic stem cells form articular cartilage, not teratomas, in osteochondral defects of rat joints. Cell Transplant. (2004) 13(4):331-336.
  • DONOVAN PJ, GEARHART J: The end of the beginning for pluripotent stem cells. Nature (2001) 414(6859):92-97.
  • DEVINE SM, COBBS C, JENNINGS M, BARTHOLOMEW A, HOFFMAN R: Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood (2003) 101(8):2999-3001.
  • BARBASH IM, CHOURAQUI P, BARON J et al.: Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation (2003) 108(7):863-868.
  • CHEN J, LI Y, WANG L et al.: Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J. Neurol. Sci. (2001) 189(1-2):49-57.
  • JI JF, HE BP, DHEEN ST, TAY SS: Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells (2004) 22(3):415-427.
  • REDDI AH: Initiation of fracture repair by bone morphogenetic proteins. Clin. Orthop. Relat. Res. (1998) (355 Suppl.):S66-S72.
  • FICKERT S, FIEDLER J, BRENNER RE: Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res. Ther. (2004) 6(5):R422-R432.
  • THORNEMO M, TALLHEDEN T, SJOGREN JANSSON E et al.: Clonal populations of chondrocytes with progenitor properties identified within human articular cartilage. Cells Tissues Organs (2005) 180(3):141-150.
  • FICKERT S, FIEDLER J, BRENNER RE: Identification, quantification and isolation of mesenchymal progenitor cells from osteoarthritic synovium by fluorescence automated cell sorting. Osteoarthritis Cartilage (2003) 11(11):790-800.
  • DE BARI C, DELL’ACCIO F, TYLZANOWSKI P, LUYTEN FP: Multipotent mesenchymaln stem cells from adult synovial membrane. Arthritis Rheum. (2001) 44(8):1928-1942.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.